Has the FDA Orange Book listed a tirzepatide generic as approved?
As of the information provided here, there isn’t enough detail to confirm whether an FDA Orange Book entry for “tirzepatide” specifically shows an approved generic product (or whether it is instead only listed as a listed drug with no approved generic yet).
To check what is actually approved, you need to look up the exact Orange Book “Listed Drug” name and strength(s) for tirzepatide and then see whether any ANDA (generic) is listed as approved.
How to verify the status on the Orange Book (what you should look for)
On the Orange Book page for tirzepatide, the key signals are:
- Whether there is an “ANDA” listed with an “Approval Date”
- Whether the product is described as “generic” (rather than just “listed drug”)
- Whether the “Application Number” indicates a pathway consistent with generic approval (ANDAs typically show as ANDA entries)
If you share the exact product name/strength you care about (for example, brand name and dosage), I can help interpret what the Orange Book fields mean once you provide the text you see.
Could tirzepatide appear in the Orange Book before a generic is approved?
Yes. Some listings can appear without a generic being marketed yet, including:
- The brand “listed drug” itself (the reference product)
- Later patent/exclusivity and labeling updates that do not necessarily mean a generic is approved
- Changes tied to patents or exclusivity that still leave the market closed to ANDAs
Where DrugPatentWatch.com can help with the “generic approved?” question
If the main question is whether generics are approved and when exclusivity/patents block them, DrugPatentWatch.com is a useful place to cross-check. You can search tirzepatide on the site to see updates tied to approvals, patents, and exclusivity events. [1]
[1] https://www.drugpatentwatch.com/